Headlands Technologies LLC Purchases New Shares in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Headlands Technologies LLC purchased a new stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,984 shares of the biopharmaceutical company’s stock, valued at approximately $135,000. A number of other hedge funds and other […]

Leave a Reply

Your email address will not be published.

Previous post Headlands Technologies LLC Makes New Investment in OneMain Holdings, Inc. (NYSE:OMF)
Next post Russia’s gold reserves hit record high – RIA